US FDA MedWatch Profile Banner
US FDA MedWatch Profile
US FDA MedWatch

@FDAMedWatch

55,565
Followers
34
Following
949
Media
2,413
Statuses

Clinically important safety information on human medical products from FDA. Comments: MedWatchComments @fda .hhs.gov Privacy:

Silver Spring, MD
Joined October 2010
Don't wanna be here? Send us removal request.
@FDAMedWatch
US FDA MedWatch
6 years
Fluoroquinolone Antibiotics: FDA Requires Labeling Changes Due to Low Blood Sugar Levels and Mental Health Side Effects
0
23
15
@FDAMedWatch
US FDA MedWatch
8 months
Do Not Use Smartwatches or Smart Rings to Measure Blood Glucose - FDA Safety Communication
Tweet media one
10
23
16
@FDAMedWatch
US FDA MedWatch
5 years
Chloroquine Phosphate Intended for Fish: FDA Letter to Stakeholders - Do Not Use as Treatment for COVID-19 in Humans
Tweet media one
2
14
16
@FDAMedWatch
US FDA MedWatch
5 months
Do Not Use Cue Health COVID-19 Tests Due to Risk of False Results: FDA Safety Communication
Tweet media one
2
14
15
@FDAMedWatch
US FDA MedWatch
8 years
EpiPen and and EpiPen Jr Auto-Injector: Recall - Failure to Activate Device
1
21
15
@FDAMedWatch
US FDA MedWatch
4 years
Hydroxychloroquine or Chloroquine for COVID-19: Drug Safety Communication - FDA Cautions Against Use Outside of the Hospital Setting or a Clinical Trial Due to Risk of Heart Rhythm Problems
Tweet media one
6
10
9
@FDAMedWatch
US FDA MedWatch
6 years
VITEK 2 Gram Positive Antimicrobial Susceptibility Testing Cards by BioMerieux: Recall - Due to False Results for Some Strains of Methicillin-Resistant Staphylococcus Aureus
2
24
13
@FDAMedWatch
US FDA MedWatch
11 years
Acetaminophen Prescription Combination Drug Products with more than 325 mg: FDA Statement - Recommendation to... http://t.co/BTTx55qbaA #FDA
2
41
11
@FDAMedWatch
US FDA MedWatch
6 years
Fluoroquinolone Antibiotics: Safety Communication - Increased Risk of Ruptures or Tears in the Aorta Blood Vessel in Certain Patients
0
23
12
@FDAMedWatch
US FDA MedWatch
8 years
Nizoral (ketoconazole) Oral Tablets: Avoid prescribing for skin and nail fungal infections, linked to patient death.
1
30
11
@FDAMedWatch
US FDA MedWatch
4 years
Remdesivir by Gilead Sciences: FDA Warns of Newly Discovered Potential Drug Interaction That May Reduce Effectiveness of Treatment
Tweet media one
0
5
10
@FDAMedWatch
US FDA MedWatch
6 years
SGLT2 (sodium-glucose cotransporter-2) Inhibitors for Diabetes: Drug Safety Communication - Regarding Rare Occurrences of a Serious Infection of the Genital Area
2
19
11
@FDAMedWatch
US FDA MedWatch
5 years
Tetrahydrocannabinol (THC)-containing Vaping Products: Vaping Illnesses
1
11
10
@FDAMedWatch
US FDA MedWatch
5 years
Ivermectin Intended for Animals: FDA Letter to Stakeholders - Do Not Use as Treatment for COVID-19 in Humans
Tweet media one
0
7
9
@FDAMedWatch
US FDA MedWatch
5 years
UPDATE: The FDA Warns that Biotin May Interfere with Lab Tests: Safety Communication
0
5
9
@FDAMedWatch
US FDA MedWatch
8 years
Certain Homeopathic Teething Products: FDA Warning - Confirmed Elevated Levels of Belladonna
0
15
9
@FDAMedWatch
US FDA MedWatch
10 years
Baby Wipes by Nutek Disposables, Inc.: Recall - May Contain Bacteria http://t.co/xFnTf0bCPP #FDAMedWatch
0
19
9
@FDAMedWatch
US FDA MedWatch
7 years
Follow FDA Commissioner on @SGottliebFDA
3
3
8
@FDAMedWatch
US FDA MedWatch
7 years
Clarithromycin (Biaxin): Drug Safety Communication - Potential Increased Risk of Heart Problems or Death in Patients With Heart Disease
0
14
8
@FDAMedWatch
US FDA MedWatch
9 years
November 2015 Drug Safety Labeling Changes includes 19 products with revisions to Prescribing Information #FDA
0
9
8
@FDAMedWatch
US FDA MedWatch
10 months
4.2% Sodium Bicarbonate Injection, 8.4% Sodium Bicarbonate Injection, and Atropine Sulfate Injection by Hospira: Recall - Due to the Potential Presence of Glass Particulate Matter
Tweet media one
2
10
8
@FDAMedWatch
US FDA MedWatch
8 years
Loperamide (Imodium): Drug Safety Communication - Serious Heart Problems With High Doses From Abuse and Misuse
1
16
8
@FDAMedWatch
US FDA MedWatch
9 years
Diabetes Medications Containing Saxagliptin and Alogliptin: Drug Safety Communication - Risk of Heart Failure
1
6
7
@FDAMedWatch
US FDA MedWatch
9 years
SGLT2 Inhibitors: Labels to Include Warnings About Too Much Acid in Blood and Serious Urinary Tract Infections #FDA
0
14
6
@FDAMedWatch
US FDA MedWatch
8 years
Fluoroquinolone Drugs: Drug Safety Communication, FDA Advises Restricting Use for Certain Uncomplicated Infections
0
19
7
@FDAMedWatch
US FDA MedWatch
9 months
Robitussin Honey CF Max Day Adult and Robitussin Honey CF Max Nighttime Adult Products by Haleon: Recall - Due to Microbial Contamination
Tweet media one
0
19
8
@FDAMedWatch
US FDA MedWatch
6 years
Children’s Advil by Pfizer: Recall - Lot# R51129 Due to Dosage Cup Mislabeling
0
8
6
@FDAMedWatch
US FDA MedWatch
10 years
Testosterone Products: Drug Safety Communication - FDA Cautions About Use for Low Testosterone Due to Aging http://t.co/kVJJy7v8mT #FDA
0
14
6
@FDAMedWatch
US FDA MedWatch
1 year
UPDATE - Akorn Issues Voluntary Nationwide Recall of Various Human and Animal Drug Products Within Expiry Due to Company Shutdown
Tweet media one
2
11
7
@FDAMedWatch
US FDA MedWatch
9 years
Licorice Coughing Liquid OTC Cough Syrup: CDER Alert - Contains Unidentified Morphine #FDA
0
10
7
@FDAMedWatch
US FDA MedWatch
6 years
Keytruda (pembrolizumab) or Tecentriq (atezolizumab): FDA Alerts Health Care Professionals and Investigators: FDA Statement - Decreased Survival in Some Patients in Clinical Trials Associated with Monotherapy
0
3
6
@FDAMedWatch
US FDA MedWatch
4 years
Hand Sanitizers by 4e Brands North America: Recall Due to Potential Presence of Undeclared Methanol (Wood Alcohol)
Tweet media one
0
6
6
@FDAMedWatch
US FDA MedWatch
5 years
Ranitidine Tablets, 150mg and 300mg, and Ranitidine Syrup (Oral Solution), 15 mg/mL by Amneal Pharmaceuticals: Recall - Due to Possible Presence of N-nitrosodimethylamine Impurity
Tweet media one
0
5
4
@FDAMedWatch
US FDA MedWatch
7 years
Codeine & Tramadol Medicines: Restricting Use in Children, Recommending Against Use in Breastfeeding Women
0
9
7
@FDAMedWatch
US FDA MedWatch
1 year
Certain Over-the-Counter Drug Products by Family Dollar: Recall - Because the Products Have Been Stored Outside of Labeled Temperature Requirements
Tweet media one
2
16
7
@FDAMedWatch
US FDA MedWatch
8 years
I.V. Flush Syringes by Nurse Assist: Recall - Potential Link to Burkholderia Cepacia Bloodstream Infections
0
8
7
@FDAMedWatch
US FDA MedWatch
6 years
Ceftriaxone for Injection by Lupin Pharmaceuticals: Recall – Due to Visual Grey Particulate Matter in Reconstituted Vials
0
4
6
@FDAMedWatch
US FDA MedWatch
7 years
Keytruda (pembrolizumab) in Patients with Multiple Myeloma: FDA Statement - Two Clinical Trials on Hold
0
15
6
@FDAMedWatch
US FDA MedWatch
5 years
FDA Warns Against the Use of Devices for Diabetes Management Not Authorized for Sale in the United States: FDA Safety Communication
0
4
6
@FDAMedWatch
US FDA MedWatch
6 years
Xeljanz, Xeljanz XR (tofacitinib): Safety Communication - Safety Trial Finds Increased Risk of Blood Clots in the Lungs and Death with Higher Dose in Rheumatoid Arthritis Patients
0
5
4
@FDAMedWatch
US FDA MedWatch
6 years
E-cigarette: Safety Communication - Related to Seizures Reported Following E-cigarette Use, Particularly in Youth and Young Adults
0
10
6
@FDAMedWatch
US FDA MedWatch
1 year
Do Not Use Certain SD Biosensor Pilot COVID-19 At-Home Tests - FDA Safety Communication
Tweet media one
0
6
4
@FDAMedWatch
US FDA MedWatch
6 years
Breast Implants: Letter to Health Care Providers - Due to Associated-Anaplastic Large Cell Lymphoma
1
2
5
@FDAMedWatch
US FDA MedWatch
6 years
Losartan Potassium Tablets by Legacy Pharmaceutical Packaging: Recall - Due to The Detection of Trace Amounts Of N-Nitroso N-Methyl 4-Amino Butyric Acid (NMBA) Impurity Found in The Active Pharmaceutical Ingredient (API) and
1
1
6
@FDAMedWatch
US FDA MedWatch
4 years
Metformin Hydrochloride for Extended-Release Oral Suspension by Sun Pharmaceutical Industries: Recall - Due to N-Nitrosodimethylamine Content Above the Acceptable Daily Intake Limit
Tweet media one
0
5
6
@FDAMedWatch
US FDA MedWatch
10 months
Select Batches of Nutramigen Hypoallergenic Infant Formula Powder by Reckitt/Mead Johnson: Recall - Due to Possible Health Risk
Tweet media one
0
16
5
@FDAMedWatch
US FDA MedWatch
8 years
Well Balance Xanthium & Siler Combo (Bi Yan Pian) by Kingsway Trading: Recall - Contains Banned Ephedra Alkaloids
0
2
4
@FDAMedWatch
US FDA MedWatch
6 years
Losartan Potassium Tablets, USP by Torrent Pharmaceuticals Limited: Expands Recall - Due to an Unexpected Impurity Found in an Active Pharmaceutical Ingredient (API)
1
4
5
@FDAMedWatch
US FDA MedWatch
8 years
Lifepak 1000 Defibrillators by Physio-Control: Voluntary Field Action - Immediately Remove and Reinstall Battery
0
5
6
@FDAMedWatch
US FDA MedWatch
8 years
Fluconazole (Diflucan): Drug Safety Comm, FDA Evaluating Study Examining Use of Oral Fluconazole in Pregnancy
0
14
5
@FDAMedWatch
US FDA MedWatch
9 years
Metformin-containing Drugs: Drug Safety Communication, Revised Warnings for Patients w/ Reduced Kidney Function
0
13
6
@FDAMedWatch
US FDA MedWatch
7 years
Fluoroquinolone Antibacterial Drugs UPDATE: Findings from published studies do not support reports of retinal detachment, aortic aneurysm
0
11
6
@FDAMedWatch
US FDA MedWatch
3 years
Stop Using LuSys Laboratories COVID-19 Tests - FDA Safety Communication
Tweet media one
11
24
5
@FDAMedWatch
US FDA MedWatch
2 months
Update:Tandem Diabetes Care, Inc. Recalls Version 2.7 of the Apple iOS t:connect Mobile App Used in Conjunction with t:slim X2 Insulin Pump with Control-IQ Technology Prompted by a Software Problem Leading to Pump Battery Depletion
Tweet media one
4
11
6
@FDAMedWatch
US FDA MedWatch
9 years
Codeine Cough & Cold Medicines in Children: Drug Safety Communication, FDA Evaluating Risk of Serious Side Effects http://t.co/Mz4jqDQwba
0
7
5
@FDAMedWatch
US FDA MedWatch
7 years
Kayexalate (sodium polystyrene sulfonate): Drug Safety Communication - FDA Recommends Separating Dosing
0
6
5
@FDAMedWatch
US FDA MedWatch
2 years
Certain Philips Respironics BiPAP Machines Recalled Due to a Plastic Issue - FDA Safety Communication
Tweet media one
0
14
5
@FDAMedWatch
US FDA MedWatch
6 months
ForeverMen by FAonline: Recall - Due Presence of Sildenafil and Tadalafil
Tweet media one
0
6
4
@FDAMedWatch
US FDA MedWatch
3 years
Potential for False Positive Results with Abbott Molecular Inc. Alinity m SARS-CoV-2 AMP and Alinity m Resp-4-Plex AMP Kits
Tweet media one
0
9
5
@FDAMedWatch
US FDA MedWatch
10 years
Prescription/Over-the-Counter Pain Medicines: Drug Safety Communication Risks of Pain Medicine Use During Pregnancy http://t.co/rAGozgPsZZ
1
6
5
@FDAMedWatch
US FDA MedWatch
4 years
EMBLEM S-ICD (Subcutaneous Implantable Cardioverter Defibrillator) System by Boston Scientific: Class I Recall - Due to Risk of Short-Circuit
Tweet media one
1
2
3
@FDAMedWatch
US FDA MedWatch
8 years
Fluoroquinolone Drugs for Systemic Use: Drug Safety Communication, Warnings Updated Due to Disabling Side Effects
0
17
5
@FDAMedWatch
US FDA MedWatch
9 years
Zerbaxa - FDA Cautions About Dose Confusion and Medication Errors http://t.co/tRgq29sUGx #FDA
0
13
5
@FDAMedWatch
US FDA MedWatch
11 years
Fluoroquinolone Antibacterial Drugs: Drug Safety Communication - Risk for possibly permanent nerve damage. http://t.co/EZLpjIzbmr
7
18
5
@FDAMedWatch
US FDA MedWatch
4 years
Hand Sanitizers: FDA Updates on Recalls Due to Dangerous, Potential Presence of Methanol (Wood Alcohol)
Tweet media one
0
7
5
@FDAMedWatch
US FDA MedWatch
3 years
Alinity m SARS-CoV-2 AMP Kit and Alinity m Resp-4-Plex AMP Kit by Abbott Molecular: Class I Recall - Due to Potential False Positive SARS-CoV-2 Test Results
Tweet media one
0
7
3
@FDAMedWatch
US FDA MedWatch
11 years
CUBICIN (daptomycin for injection) by Cubist Pharmaceuticals: Recall - Presence of Particulate Matter http://t.co/UtvQBkNJKK #MedWatch
0
4
5
@FDAMedWatch
US FDA MedWatch
6 years
Impella RP System by Abiomed: Letter to Health Care Providers - Increased Rate of Mortality
0
1
5
@FDAMedWatch
US FDA MedWatch
10 years
Zyprexa Relprevv (olanzapine pamoate): Safety Communication - FDA Review of Study Sheds Light on Two Deaths http://t.co/QMuhXwmEgf
0
9
5
@FDAMedWatch
US FDA MedWatch
10 years
February 2015 Safety Labeling Changes posting includes 45 products with changes to Prescribing Information http://t.co/plxuOqYIOo #FDA
0
5
5
@FDAMedWatch
US FDA MedWatch
3 years
Select Monoject Flush Prefilled Saline Syringes By Cardinal Health: Recall - Products have been found to reintroduce air into the syringe after the air has been expelled
Tweet media one
0
2
5
@FDAMedWatch
US FDA MedWatch
4 years
Infections Associated with Reprocessed Urological Endoscopes - Letter to Health Care Providers
Tweet media one
0
2
5
@FDAMedWatch
US FDA MedWatch
4 years
Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Drug Safety Communication - Avoid Use of NSAIDs in Pregnancy at 20 Weeks or Later
Tweet media one
0
5
5
@FDAMedWatch
US FDA MedWatch
7 years
General Anesthetic & Sedation Drugs: Drug Safety Commun - FDA Approves Label Changes for Use in Young Children
0
4
5
@FDAMedWatch
US FDA MedWatch
4 years
Genetic Variants of SARS-CoV-2 May Lead to False Negative Results with Molecular Tests for Detection of SARS-CoV-2 - Letter to Clinical Laboratory Staff and Health Care Providers
Tweet media one
0
2
4
@FDAMedWatch
US FDA MedWatch
8 years
Go to FDA MedWatch for clinically important safety information & reporting serious problems w human medical products
1
8
5
@FDAMedWatch
US FDA MedWatch
4 years
Metformin Hydrochloride Extended-Release Tablets USP, 500 mg by Marksans: Recall - Due to the Detection of N-Nitrosodimethylamine
Tweet media one
0
0
5
@FDAMedWatch
US FDA MedWatch
8 years
Breast Implants: Update - Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL)
0
8
5
@FDAMedWatch
US FDA MedWatch
5 years
Lung Injury Update: FDA Warns Public to Stop Using Tetrahydrocannabinol (THC)-Containing Vaping Products and Any Vaping Products Obtained Off the Street
0
5
5
@FDAMedWatch
US FDA MedWatch
8 years
Over-the-Counter Antacid Products Containing Aspirin: FDA Drug Safety Communication - Serious Bleeding Risk #FDA
0
20
5
@FDAMedWatch
US FDA MedWatch
6 years
Zithromax, Zmax (azithromycin): FDA Warning - Increased Risk of Cancer Relapse With Long-Term Use After Donor Stem Cell Transplant
0
7
5
@FDAMedWatch
US FDA MedWatch
5 years
All Ranitidine Products (Zantac): Press Release - FDA Requests Removal
Tweet media one
0
5
5
@FDAMedWatch
US FDA MedWatch
5 years
Singulair (montelukast) and All Montelukast Generics: Strengthened Boxed Warning - Due to Advice on Restricting Use for Allergic Rhinitis
Tweet media one
0
4
5
@FDAMedWatch
US FDA MedWatch
4 years
Risk of False Results with the Curative SARS-Cov-2 Test for COVID-19: FDA Safety Communication
Tweet media one
0
7
4
@FDAMedWatch
US FDA MedWatch
10 years
Over-the-Counter Asthma Products Labeled as Homeopathic: FDA Statement- Consumer Warning About Potential Health Risks http://t.co/TqxMW2yDlT
0
17
5
@FDAMedWatch
US FDA MedWatch
5 years
Fecal Microbiota for Transplantation: Safety Alert - Risk of Serious Adverse Events Likely Due to Transmission of Pathogenic Organisms
Tweet media one
0
0
5
@FDAMedWatch
US FDA MedWatch
9 years
Gadolinium-based Contrast Agents for MRI: Drug Safety Comm, FDA Evaluating Risk of Brain Deposits With Repeated Use http://t.co/jl823LwVJq
0
11
5
@FDAMedWatch
US FDA MedWatch
2 years
Certain Lots of Top of the Rockies Alfalfa Cubes by Manzanola Feeds: Recall - Due to Possible Clostridium botulinum Health Risk
Tweet media one
0
8
5
@FDAMedWatch
US FDA MedWatch
7 years
Imodium (loperamide) for Over-the-Counter Use: Drug Safety Communication - FDA Limits Packaging To Encourage Safe Use
0
7
4
@FDAMedWatch
US FDA MedWatch
6 years
TB Temporary Bipolar Pacing Leads by Oscor: Recall - Due to Connector Separation Causing Potential for Loss of Pacing
0
0
4
@FDAMedWatch
US FDA MedWatch
2 years
Epinephrine (L-Adrenaline) USP Bulk Active Pharmaceutical Ingredient by Spectrum Laboratory Products: Recall - Due to Discoloration of Product
Tweet media one
1
4
4